Picking embryos with best health odds sparks new DNA debate

A handful of companies in the US and Europe are offering embryo risk scores for conditions including schizophrenia, breast cancer and diabetes.
PHOTO ILLUSTRATION: ST FILE
A handful of companies in the US and Europe are offering embryo risk scores for conditions including schizophrenia, breast cancer and diabetes. PHOTO ILLUSTRATION: ST FILE

BOSTON (BLOOMBERG) - Dr Rafal Smigrodzki will not make a big deal of it, but someday, when his toddler daughter Aurea is old enough to understand, he plans to explain that she likely made medical history at the moment of her birth.

Aurea appears to be the first child born after a new type of DNA testing that gave her a "polygenic risk score". It is based on multiple common gene variations that could each have tiny effects. Together, they create higher or lower odds for many common diseases.

Please or to continue reading the full article.

Get unlimited access to all stories at $0.99/month
  • Latest headlines and exclusive stories
  • In-depth analyses and award-winning multimedia content
  • Get access to all with our no-contract promotional package at only $0.99/month for the first 3 months*

*Terms and conditions apply.